Allergologia et immunopathologia: International journal for clinical and investigate allergology and clinical immunology

• 

  Año 2010, Vol. 38, Número 4

  • Measuring potency of allergenic extracts.

    I. Finegold

    pág. 169

    

  • A comparison of in vitro potency between European and Mexican allergen extracts and US (CBER/FDA) reference extracts.

    D. Larenas-Linnemann, R.E. Esch, G. Guidos-Fogelbach, N. Rodriguez-Pérez

    • Resumen

    págs. 170-173

    

  • Prevalence and factors linked to atopic eczema in 10- and 11-year-old schoolchildren: Isaac 2 in Almeria, Spain.

    José Batlles Garrido, Javier Torres Borrego, Antonio Bonillo Perales, T. Rubí Ruiz, Y. González Jiménez, J. Momblán De Cabo, J. Aguirre Rodríguez, R. Jiménez Liria, A. Losilla Maldonado, M. Daza Torres

    • Resumen

    págs. 174-180

    

  • The prevalence of aspirin-induced asthma in Saudian asthmatic patients.

    E.Y. Sabry

    • Resumen

    págs. 181-186

    

  • Clinical significance of cross-reactivity between tobacco and latex.

    Alicia Armentia Medina, Antonio Dueñas Laita, B. Bartolomé, Francisco Javier Martín Gil, Ángel San Miguel Hernández, Javier Castrodeza Sanz

    • Resumen

    págs. 187-196

    

  • Specific pattern of flea antigen recognition by IgG subclass and IgE during the progression of papular urticaria caused by flea bite.

    A. Cuéllar, A. Rodríguez, E. Halpert, F. Rojas, A. Gómez, A. Rojas, E. García

    • Resumen

    págs. 197-202

    

  • Poverty-associated risk factors for wheezing in the first year of life in Honduras and El Salvador.

    A. Bueso, M. Figueroa, L. Cousin, W. Hoyos, Antonela Martínez Torres, J. Mallol, Luis Vicente García-Marcos Álvarez

    • Resumen

    págs. 203-212

    

  • Lung function testing in pre-school children.

    R. Dinwiddie

    págs. 213-216

    

  • Microarrays: Molecular allergology and nanotechnology for personalised medicine (II).

    J.M Lucas

    • Resumen

    págs. 217-223

    

  • Anaphylaxis to mefenamic acid in a patient with new onset of systemic lupus erythematosus.

    M. Couto, C. Duarte, L. Geraldes, L. Inês, A. Malcata

    págs. 224-226

    

  • Systemic anaphylaxis caused by moxifloxacin.

    Leticia Sánchez Morillas, P. Rojas Pérez-Ezquerra, M. Reaño Martos, J.J. Laguna Martínez, P. Gómez-Tembleque

    págs. 226-227

    

  • Isoniazid hepatitis: are immunological mechanisms implicated?

    J.A. Martínez-Tadeo, Ricardo González Pérez, G. Hernández-Santana

    pág. 228